Search

everythinglearnresearchcommunity

for

Search:↓

Potassium channel openers are effective in treating heart conditions, high blood pressure, pulmonary diseases, bladder issues, and hair loss, but more selective drugs are needed.

Some blood-thinning medications can increase the risk of bleeding, and certain factors like genetics and other health conditions affect their safety and effectiveness.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

PRP injections can effectively and safely treat alopecia areata.

Microneedling helps with hair loss, especially with 5% minoxidil, but more high-quality research is needed.

A lotion with natural extracts significantly sped up hair growth in women with hair loss from chemotherapy.

Intermittent fasting slows hair growth by damaging hair follicle cells.

Low-dose oral minoxidil may help treat hair loss but is not FDA-approved and can cause side effects like unwanted hair growth and heart issues.

Alopecia areata needs more recognition and better treatment access in Latin America to improve patient care and outcomes.

Dutasteride is the most effective hair loss treatment after 24 weeks, but finasteride leads to the most hair growth after 48 weeks.

Saw palmetto may cause erectile dysfunction and needs better safety monitoring.

Wounding may stimulate hair growth, but more research is needed to confirm the safety and effectiveness of related treatments.

Direct vasodilators and sympatholytic agents are still useful for certain conditions despite being less common due to side effects and newer drugs.

There is no gold standard treatment for hidradenitis suppurativa due to insufficient evidence.

5-alpha-reductase inhibitors may help stabilize or slow down hair loss in some frontal fibrosing alopecia patients, but more research is needed to confirm their effectiveness and safety.

PRP therapy works better than minoxidil for treating hair loss.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Sequential therapy with dupilumab and baricitinib improved hair regrowth and atopic dermatitis in a child without adverse reactions.

Using lyopreserved umbilical tissue allograft may improve healing and reduce recurrence of pilonidal cysts.

No single treatment is clearly effective for central serous chorioretinopathy.

Platelet-derived bio-products help in wound healing and tissue regeneration but lack standardized methods, and their use in medicine is growing.

Chitosan scaffolds with silver nanoparticles effectively treat infected wounds and promote faster healing.

Polycystic ovary syndrome and iron overload share similar symptoms and can be potentially treated with blood removal, diet changes, and probiotics.

Dutasteride, usually used for prostate issues and hair loss, could potentially treat Amyotrophic Lateral Sclerosis (ALS) due to its neuroprotective, antioxidant, and anti-inflammatory properties, but more testing is needed.

Finasteride and Dutasteride can improve hair growth in male baldness but may cause temporary sexual dysfunction and possibly affect fertility.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Systemic treatment is necessary for tinea capitis in children, with griseofulvin preferred for Microsporum infections.

Colchicine might help treat different skin diseases, but more research is needed to confirm its effectiveness and safe dosage.

Some nutraceuticals may help in COVID-19 prevention and treatment, but more research is needed.

Using protein degradation to fight cancer drug resistance shows promise but needs more precise targeting and fewer side effects.